Skip to main content
Grant Details

Grant Number: 7R03CA191447-02 Interpret this number
Primary Investigator: Waldron, Levi
Organization: Graduate School Of Public Health And Health Policy
Project Title: Validation and Clinical Relevance of Ovarian Cancer Molecular Subtypes
Fiscal Year: 2016
Back to top


 DESCRIPTION (provided by applicant): At least five major studies have reported molecular subtypes of high-grade, serous ovarian cancer, and these have the potential to guide development of targeted treatments. However, each study has proposed overlapping but different subtype algorithms, and have used small and differing subsets of publicly available data for validation. At least two other major ovarian cancer studies could not identify discrete subtypes in their gene expression data at all. Uncertainty in the clinical relevance of proposed subtypes is compounded by recent reports that most ovarian cancer tumors are multi-clonal, raising the possibility that multiple subtypes exist within a single tumor. Thus the nature of ovarian cancer subtypes remains controversial, even as they have spurred further investment in retrospective analysis of clinical trial specimens. This study aims to resolve controversy and uncertainty in the nature of ovarian cancer subtypes by two main approaches. First, subtype robustness and association to patient outcome are assessed by comparative meta-analysis using all relevant publicly available data. This will provide clarity on which definition of subtyps future research should focus on. Second, the likely ordering of subtype differentiation in tumor evolution is determined by analysis of the allele frequencies of subtype- associated DNA short variants in data from The Cancer Genome Atlas. This application moves the field of ovarian cancer research forward by resolving controversy around proposed subtypes using publicly available data, and by providing standardized definitions of subtype algorithms with documentation for their application to new patients.

Back to top


The impact of different sources of heterogeneity on loss of accuracy from genomic prediction models.
Authors: Zhang Y. , Bernau C. , Parmigiani G. , Waldron L. .
Source: Biostatistics (Oxford, England), 2020-04-01; 21(2), p. 253-268.
PMID: 30202918
Related Citations

MetaGxData: Clinically Annotated Breast, Ovarian and Pancreatic Cancer Datasets and their Use in Generating a Multi-Cancer Gene Signature.
Authors: Gendoo D.M.A. , Zon M. , Sandhu V. , Manem V.S.K. , Ratanasirigulchai N. , Chen G.M. , Waldron L. , Haibe-Kains B. .
Source: Scientific reports, 2019-06-19; 9(1), p. 8770.
EPub date: 2019-06-19.
PMID: 31217513
Related Citations

Consensus on Molecular Subtypes of High-Grade Serous Ovarian Carcinoma.
Authors: Chen G.M. , Kannan L. , Geistlinger L. , Kofia V. , Safikhani Z. , Gendoo D.M.A. , Parmigiani G. , Birrer M. , Haibe-Kains B. , Waldron L. .
Source: Clinical cancer research : an official journal of the American Association for Cancer Research, 2018-10-15; 24(20), p. 5037-5047.
EPub date: 2018-07-03.
PMID: 30084834
Related Citations

Continuity of transcriptomes among colorectal cancer subtypes based on meta-analysis.
Authors: Ma S. , Ogino S. , Parsana P. , Nishihara R. , Qian Z. , Shen J. , Mima K. , Masugi Y. , Cao Y. , Nowak J.A. , et al. .
Source: Genome biology, 2018-09-25; 19(1), p. 142.
EPub date: 2018-09-25.
PMID: 30253799
Related Citations

The Doppelgänger Effect: Hidden Duplicates in Databases of Transcriptome Profiles.
Authors: Waldron L. , Riester M. , Ramos M. , Parmigiani G. , Birrer M. .
Source: Journal of the National Cancer Institute, 2016 11; 108(11), .
EPub date: 2016-07-05.
PMID: 27381624
Related Citations

Racial/Ethnic Disparities in Genomic Sequencing.
Authors: Spratt D.E. , Chan T. , Waldron L. , Speers C. , Feng F.Y. , Ogunwobi O.O. , Osborne J.R. .
Source: JAMA oncology, 2016-08-01; 2(8), p. 1070-4.
PMID: 27366979
Related Citations

Back to Top